Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation (Q38614498)

4 September 2017

Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation (English)

1 reference

4 September 2017

1 reference

1 reference

Karin Frank-Raue

1

1 reference

PubMed ID

26494387

4 September 2017

Friedhelm Raue

series ordinal

2

1 reference

4 September 2017

1 January 2015

1 reference

Recent Results in Cancer Research

4 September 2017

1 reference

4 September 2017

204

1 reference

4 September 2017

139-156

1 reference

RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.

4 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Reference intervals for serum calcitonin in men, women, and children

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

A Novel Germ-Line Point Mutation in RET Exon 8 (Gly533Cys) in a Large Kindred with Familial Medullary Thyroid Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

A rareRETgene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Medullary thyroid cancer: management guidelines of the American Thyroid Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Pheochromocytoma penetrance varies by RET mutation in MEN 2A

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Genotype-phenotype correlation in multiple endocrine neoplasia type 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Primary hyperparathyroidism in multiple endocrine neoplasia type 2A

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Medullary thyroid cancer in a 9-week-old infant with familial MEN 2B: Implications for timing of prophylactic thyroidectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Frequent association between MEN 2A and cutaneous lichen amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: s

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22542-5_6

10.1007/978-3-319-22542-5_6

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26494387